Ypsomed Holding AG Logo

Ypsomed Holding AG

Develops self-injection systems for pharma/biotech partners to simplify chronic disease therapy.

YPSN | SW

Overview

Corporate Details

ISIN(s):
CH0019396990
LEI:
391200QLIOTTBNPNSI14
Country:
Switzerland
Address:
Brunnmattstrasse 6, 3400 Burgdorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Ypsomed Holding AG is a leading developer and manufacturer of self-injection and infusion systems for self-medication. The company partners with pharmaceutical and biotech companies, providing a comprehensive portfolio of innovative platforms including injection pens, autoinjectors, and on-body devices. For over 40 years, Ypsomed has offered tailored self-care solutions designed to simplify therapy and improve quality of life for people with chronic conditions. Its platform ecosystem combines industrialized drug delivery technology with expert support services and integrated digital health solutions that support therapy management and clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ypsomed Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ypsomed Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ypsomed Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-30 N/A Executive member Buy None 145,600.00 CHF
2024-09-26 N/A Executive member Sell None 129,352.00 CHF
2024-09-24 N/A Non-Executive member Buy None 42,776.00 CHF
2024-05-27 N/A Executive member Sell None 78,000.00 CHF
2024-05-22 N/A Executive member Sell None 154,000.00 CHF
2023-09-29 N/A Executive member Sell None 40,800.00 CHF
2022-06-23 N/A Non-Executive member Buy None 31,400.00 CHF
2022-06-23 N/A Executive member Buy None 11,760.00 CHF
2022-06-23 N/A Executive member Buy None 122.50 CHF
2022-06-14 N/A Non-Executive member Buy None 1,080,875.72 CHF

Peer Companies

Senseonics Holdings, Inc. Logo
Develops the first long-term, implantable glucose sensor for diabetes management.
United States of America
SENS
Sequana Medical N.V. Logo
Develops implantable devices to treat drug-resistant fluid overload from cirrhosis and heart failure.
Belgium
SEQUA
SEWOONMEDICAL CO,. LTD. Logo
Researches, develops, produces, and sells high-quality consumable medical products.
South Korea
100700
Sharps Technology Inc. Logo
Develops patented safety syringes for healthcare while managing a digital asset treasury.
United States of America
STSS
Global manufacturer of dental implants, alloys, and surgical kits for dental professionals.
South Korea
004080
SHOFU INC. Logo
Global manufacturer of dental materials, equipment, and nail care products for dental professionals.
Japan
7979
SHOULDER INNOVATIONS, INC. Logo
Develops advanced shoulder arthroplasty implant systems for surgeons in hospitals and ASCs.
United States of America
SI
SI-BONE, Inc. Logo
Develops MIS implants for sacroiliac joint dysfunction causing chronic low back pain.
United States of America
SIBN
Sight Sciences, Inc. Logo
Develops interventional ophthalmic solutions like the OMNI® Surgical System for glaucoma.
United States of America
SGHT
Slavej AD Logo
Manufactures and distributes orthotics and prosthetics for people with physical disabilities.
North Macedonia
SLAV

Talk to a Data Expert

Have a question? We'll get back to you promptly.